Rojymon Jacob

NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: 5-Year Toxicity and Biochemical Recurrence Results From a Prospective Trial

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019

Advances in pancreatic cancer biomarkers

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017

Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer

Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma

Improved Postoperative Survival for Intraductal- Growth Subtype of Intrahepatic Cholangiocarcinoma

Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of ≥3 cm

Intensity-modulated Radiation Therapy for Anal Cancer

Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy

Flattening filter‐free linac improves treatment delivery efficiency in stereotactic body radiation therapy

Optimal Planning Target Volume Margins for Elective Pelvic Lymphatic Radiotherapy in High-Risk Prostate Cancer Patients

A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases

Radiation Necrosis in the Brain: Imaging Features and Differentiation from Tumor Recurrence